SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: biowa who wrote (35)9/4/1997 7:10:00 PM
From: Pseudo Biologist   of 3044
 
Thanks for sharing your thoughts. I just came back from vacation and have spent the last few days catching up.

It is true that their business model has become a lot more complex and high-maintenance; the latter leads to concerns regarding burn rate; the former leads to money managers and analysts having a hard time putting a valuation on this company.

Since the original brouhaha re. EST's back in the days of Dr. Venter I have not seen major developments on this issue. I seem to recall that the patent office was leaning towards denying the usefulness quality to "plain" ESTs (as an aside it looks as if the recent Geron publication relied on a previously known EST as I recall from my reading of the Science paper a couple of weeks ago).

I agree that the science seems to remain first rate and today's announcement re. SAB reaffirms this (but, I thought Lander and a few others mentioned today had been associated with MLNM all along, so what's the news here?).

PB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext